At the request of the Food and Drug Administration, the four companies that have teriparatide products (FOREO by Lilly and generics by Prasco, Teva, and Apotex) are changing package size on the label although they are not changing NDCs. Changing package size will affect claims billing while labels with both package sizes are in distribution. Pharmacies should be on the alert for possible overpayment or underpayment (e.g., when package size in the drug file is 2.4mL and 2.24mL is submitted or vice versa). Similarly, pharmacies need to understand which package size is in their pharmacy system drug file to understand the dispense quantity that should be entered when submitting a claim.
NCPA
